New databank to develop treatments for human infertility.
Infertility is a growing problem in our society. The number of embryo transfers performed in Europe (the last human-controlled step of the in-vitro fertilisation technique) increased by 8% between 1999 and 2003. Recent studies confirm this rising trend.
Despite the advances in IVF and other assisted reproduction technologies (ART), only 25% of embryo transfer attempts will lead to a successful pregnancy. In the remaining 75% of cases, the embryo fails to implant into the mother’s uterus. In many cases this may be due to the embryo being ‘rejected’ by the mother’s immune system. The way in which “rejection” is avoided when an embryo implants successfully and what goes wrong when it fails to implant are poorly understood. “The answers to these questions are crucial for the treatment of infertility” says Professor Ian Sargent, of the University of Oxford and EMBIC member (www.embic.org).
To try to resolve this problem, EMBIC has launched a database on human infertility. Our member laboratories will analyze the results of both our basic research and clinical data.
“By combining these observations (basic and clinical), we will be able to develop better treatment protocols in the future” declared Dr. Nathalie Lédée of the Université de Versailles Saint Quentin en Yvelines and the person responsible of the EMBIC Database on Human Infertility. The studies that are being carried out require access to large numbers of clinical samples that could never be collected in one IVF Unit or hospital working in isolation. Only by a joint international effort will we be able to produce the results that we need.
The EMBIC database will be located in France and will bring together, anonymously and coded, the clinical information of fertile and infertile volunteers from 8 IVF centres from 7 European countries. The EMBIC scientists will complete this information by entering into the database the results of the tests carried out on these samples, using the latest technologies for molecular and cell biology.
“The strength of EMBIC is that by working together, large numbers of samples can be collected in a short space of time. It also allows direct comparisons between different treatments carried out in different countries across Europe” says Professor Sargent. The EMBIC scientists are convinced that this shared effort “will provide new insights into the causes of infertility and will lead to novel, targeted treatments for this very distressing condition”.
Juarez Perez Victor | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...